Viewing nowNew Satan Tablet 160 mg (Valsartan)
Valsartan 160mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

MFDS item code 201300127 · Approved 2013.01.08 · Insurance code 654304690
Treatment of essential hypertension and heart failure; reduction of the risk of death after myocardial infarction
This medication is used to effectively lower and manage blood pressure in patients with essential hypertension. It can also be safely used in heart failure patients who are intolerant to ACE inhibitors and helps reduce the mortality risk in patients with decreased left ventricular function after a myocardial infarction. Through these actions, it helps to regulate blood pressure and protect cardiac function, thus improving overall cardiovascular health.
1. Essential hypertension Take with water during or between meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. 1) Adults: The recommended dose is 80 mg of valsartan orally once daily, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg once daily or a diuretic may be coadministered. If additional blood pressure reduction is needed, the dose may be increased up to a maximum of 320 mg once daily. 2) Older adults (75 years or older): Initiate treatment with 40 mg of this drug once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with 40 mg of this drug once daily. (3) Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this drug. 4) Patients with volume depletion: For patients with intravascular volume depletion (e.g., patients taking high doses of diuretics whose doses cannot be reduced), initiate treatment with 40 mg of this drug once daily. 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, initiate treatment with 40 mg of this drug once daily; the dose should not exceed 80 mg once daily. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this drug orally twice daily; the dose may be increased to 80 mg or 160 mg per dose. Consider reducing the dose of a concomitantly administered diuretic. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this drug, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours after the onset of myocardial infarction. The recommended starting dose is 20 mg of this drug twice daily, followed over several weeks by dose increases to 40 mg, 80 mg, and 160 mg per dose twice daily, taking the patient's tolerability into account. Consider dose reduction if symptoms of hypotension or renal impairment occur. This drug may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytics, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary if creatinine clearance is 10 mL/min or greater. However, do not administer this drug to patients with creatinine clearance less than 10 mL/min or to patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of this drug should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this drug to patients with severe hepatic impairment, cirrhosis, or cholestasis.
The safety and efficacy have not been established in children and adolescents under 18 years of age.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to this drug or its components, women who are pregnant or may become pregnant, nursing mothers, patients with severe liver impairment or cirrhosis, and those with severe renal impairment should not take this medication. Elderly patients, those with high potassium levels, patients with mild to moderate liver impairment, patients with heart disease, and those scheduled for surgery should take this medication with caution. Blood pressure may suddenly drop during the initial treatment, leading to dizziness or fainting; if these symptoms occur, consult a doctor immediately. Regular checks of blood pressure, renal function, and blood potassium levels are necessary during treatment to ensure no abnormalities. Particularly, when taking with other antihypertensive medications, diuretics, or potassium supplements, interactions may cause side effects, so consultation with a doctor is essential. This medication is not recommended for use in children and adolescents as its safety and efficacy have not been established. In case of overdose, severe hypotension or decreased consciousness may occur, so care should be taken not to exceed the recommended dose.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and should be kept in a cool place below 30 degrees Celsius, avoiding heat exposure. Storing it this way can maintain the effectiveness of the medication and prevent deterioration.
Oval film-coated tablet in orange color with a grayish tint
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 160mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.